Company intelligence / Profile preview

Biorce

Barcelona, Catalonia, Spainbiorce.com ↗

Ownership: Private
Development stage: Other

Overview

Biorce has developed Jarvis, an AI-driven platform designed to aggregate and cross-reference real-time data from multiple sources in the clinical trial process. The goal is to reduce costs by over 50% and shorten timelines by more than 40%, addressing inefficiencies, data fragmentation, and logistical hurdles that slow down drug development. The company recently closed a €3.5 million funding round to accelerate product development

Therapeutic areas: Other
Modalities: Not directly applicable (Biorce is a platform/technology provider, not a drug developer)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Private data partnerships across the clinical trial ecosystem are mentioned but no specific companies named yet

Beyond the preview

Go deeper on Biorce.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorce.

Explore the full profile